Magnesium intake is associated with the metabolically healthy obese phenotype
Guerrero-Romero F, Morales-Gurrola G, Preza-Rodríguez L, Gómez-Barrientos A, Olivas-Martínez AI, Simental-Mendía LE
Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 9 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Estudio transversal (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2021-11-01 · J Investig Med · vol. 70 · número 3 · págs. 800–804
- Editorial
- SAGE Publishing
- Citado
- 8 citas · más que el 63% de estudios similares · 0.6× el promedio de su campo
- Referencias
- 24 trabajos
- Acceso
- De pago
- Áreas de investigación
- Magnesium in Health and Disease · Parathyroid Disorders and Treatments
- Palabras clave
- Medicine, Hypertriglyceridemia, Internal medicine, Blood pressure, Endocrinology, Waist, Abdominal obesity, Obesity, Triglyceride, Cholesterol
- MeSH
- humans, obesity, magnesium, body mass index, risk factors, cross-sectional studies, phenotype, female, obesity, abdominal, metabolic syndrome
6 autores
- Fernando Guerrero‐Romero🇲🇽Mexican Social Security Institute
- Gerardo Morales-Gurrola🇲🇽Mexican Social Security Institute; Universidad Juárez del Estado de Durango
- Lucia Preza‐Rodríguez🇲🇽Mexican Social Security Institute; Universidad Juárez del Estado de Durango
- Alejandra Gómez-Barrientos🇲🇽Mexican Social Security Institute
- Ana I Olivas-Martínez🇲🇽Mexican Social Security Institute
- Luis E. Simental‐Mendía🇲🇽 · autor de correspondenciaMexican Social Security Institute
Resumen
El texto original del estudio, en el idioma en que se publicó.
Although magnesium intake is inversely associated with the risk of metabolic abnormalities, whether magnesium intake plays a role on metabolically healthy obese (MHO) phenotype has not been explored. Therefore, the purpose of this study was to determine whether the magnesium intake is associated with the MHO phenotype. Apparently, healthy women and men aged 20-65 years with obesity were enrolled in a cross-sectional study. Subjects were allocated into MHO (n=124) and metabolically unhealthy obese (MUO) (n=123) groups. MHO phenotype was defined by abdominal obesity (waist circumference ≥90 cm in men and ≥80 cm in women) and none, or not more than one of the following risk factors: triglyceride levels ≥150 mg/dL; high-density lipoprotein cholesterol (HDL-C) levels <40 mg/dL in men and <50 mg/dL in women; fasting glucose ≥100 mg/dL; and systolic blood pressure ≥130 mm Hg and/or diastolic blood pressure ≥85 mm Hg. The MUO individuals were characterized by abdominal obesity and the presence of two or more of the aforementioned criteria. The proportion of individuals with high blood pressure (40.7% vs 5.6%, p<0.001), hyperglycemia (69.1% vs 16.9%, p<0.001), hypertriglyceridemia (84.6% vs 36.3%, p<0.001), and low HDL-C (51.2% vs 12.9%, p<0.001) was significantly higher in the MUO individuals as compared with individuals in the MHO group. The logistic regression analysis adjusted by sex and age showed that dietary magnesium intake is significantly associated with the MHO phenotype (OR=1.17; 95% CI 1.07 to 1.25, p=0.005). Our results show that magnesium intake is significantly associated with the MHO phenotype.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.